Related Experiment Video
Updated: Mar 31, 2026

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
Published on: October 28, 2020
Impact of Left Ventricular Geometry on All-Cause Mortality in Patients Undergoing Hemodialysis: A Longitudinal
Yoshihiro Nakamura1, Shimon Kurasawa1, Toru Kondo2
1Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Insights
Left ventricular geometry abnormalities, particularly concentric hypertrophy and remodeling, significantly increase mortality risk in hemodialysis patients. Echocardiography can help predict this risk.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Medical Imaging
Background:
- Left ventricular (LV) geometry classification predicts mortality in hypertension but is inconclusive in hemodialysis patients.
- LV geometry is categorized into four types based on LV mass index and relative wall thickness.
- Understanding LV geometry is crucial for risk stratification in chronic kidney disease patients.
Purpose of the Study:
- To evaluate the association between four categories of LV geometry and all-cause mortality in hemodialysis patients.
- To determine if LV geometry classification improves mortality risk prediction beyond LV hypertrophy alone.
- To assess the prevalence of different LV geometry patterns in this population.
Main Methods:
- Retrospective multicenter cohort study in Japan (October 2006 - December 2021).
- Included 2228 maintenance hemodialysis patients who underwent echocardiography.
- Exposure: LV geometry abnormalities (concentric remodeling, eccentric hypertrophy, concentric hypertrophy). Outcome: All-cause death.
Main Results:
- Nearly 80% of patients had abnormal LV geometry: concentric hypertrophy (30%) and concentric remodeling (27%) were most common.
- Concentric hypertrophy (aHR 1.32) and concentric remodeling (aHR 1.27) were associated with significantly higher all-cause mortality risk compared to normal geometry.
- Eccentric hypertrophy showed a similar mortality risk (aHR 1.03) to normal geometry.
Conclusions:
- Abnormal LV geometry is highly prevalent in hemodialysis patients, with concentric hypertrophy and remodeling posing the greatest mortality risk.
- Standard LV hypertrophy assessment misses the risk associated with concentric remodeling.
- Echocardiography-based LV geometry assessment offers valuable risk prediction for hemodialysis patients.
Key Points:
We evaluated the association between the four categories of left ventricular geometry and all-cause mortality in patients undergoing hemodialysis. Concentric hypertrophy was the most prevalent, followed by concentric remodeling, and these were associated with a high risk of mortality. Echocardiography screening for evaluating the four categories of left ventricular geometry may be useful for risk prediction in patients undergoing hemodialysis.
Background:
Left ventricular (LV) geometry, which is classified into four categories on the basis of left ventricular mass index and relative wall thickness, can predict mortality more accurately than the presence of LV hypertrophy alone in patients with hypertension. However, this association remains inconclusive in patients undergoing maintenance hemodialysis.
Methods:
We conducted a retrospective multicenter cohort study involving patients undergoing maintenance hemodialysis in Japan who underwent echocardiography between October 2006 and December 2021. The exposure of interest was LV geometry abnormalities (concentric remodeling, eccentric hypertrophy, and concentric hypertrophy). The primary outcome of this study was all-cause death.
Results:
Among the 2228 patients included in the analysis (mean age, 67 years; 67% male individuals; median dialysis vintage, 1.5 years), 476 (21%) had normal geometry, 592 (27%) had concentric remodeling, 493 (22%) had eccentric hypertrophy, and 667 (30%) had concentric hypertrophy. During a median follow-up period of 3.8 years, 825 patients (37%) died. Compared with patients with normal geometry, those with concentric hypertrophy (adjusted hazard ratio [aHR], 1.32; 95% confidence interval [CI], 1.06 to 1.63) and concentric remodeling (aHR, 1.27; 95% CI, 1.02 to 1.58) had a higher risk of mortality. Eccentric hypertrophy was associated with a similar risk of mortality (aHR, 1.03; 95% CI, 0.81 to 1.30) compared with normal geometry.
Conclusions:
Approximately 80% of patients undergoing maintenance hemodialysis exhibited abnormal LV geometry, with concentric hypertrophy being the most common pattern, followed by concentric remodeling. These abnormalities were associated with a higher risk of all-cause mortality compared with normal geometry. Risk prediction on the basis of the presence or absence of LV hypertrophy cannot consider concentric remodeling; therefore, echocardiography screening for evaluating the four categories of LV geometry may be beneficial in patients undergoing hemodialysis.
Related Concept Videos
Heart Failure II: Pathophysiology
Hemodialysis I: Introduction
Pathophysiology of Heart Failure
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hemodialysis II: Procedure and Complications
Mitral Regurgitation I: Introduction

